LoginRegister
    Cancer Drug Patent Issues: Delhi HC junks Bayer plea to block Natco Pharma RegonatCancer Drug Patent Issues: Delhi HC junks Bayer plea to block Natco Pharma Regonat
    Sun Pharma unveils Ezallor Sprinkle capsules for treating lipid disorder in USSun Pharma unveils Ezallor Sprinkle capsules for treating lipid disorder in US
    GSK to appoint Novartis, Astrazeneca ex-executive Jonathan Symonds as new Chairman: BloombergGSK to appoint Novartis, Astrazeneca ex-executive Jonathan Symonds as new Chairman: Bloomberg
    Lupin to focus on launch of biosimilar, inhalation product in US this fiscalLupin to focus on launch of biosimilar, inhalation product in US this fiscal
    Gilead to raise stake in Belgian Biotech Galapagos in USD 5.1 billion deal: ReportGilead to raise stake in Belgian Biotech Galapagos in USD 5.1 billion deal: Report
    First-in-human Trial: Cyxone begins Phase 1 trial with T20K for treatment of multiple sclerosisFirst-in-human Trial: Cyxone begins Phase 1 trial with T20K for treatment of multiple sclerosis
    Rejected: JnJ plea to waiver Phase IV trial for FDC drug containing Canagliflozin, MetforminRejected: JnJ plea to waiver Phase IV trial for FDC drug containing Canagliflozin, Metformin
    Aurobindo Pharma in focus on launch of generic version of Sensipar tablets in USAurobindo Pharma in focus on launch of generic version of Sensipar tablets in US
    Laurus Labs gets no USFDA observations for Vizag unitLaurus Labs gets no USFDA observations for Vizag unit
    Eton Pharma fails to win USFDA nod for conjunctivitis treatmentEton Pharma fails to win USFDA nod for conjunctivitis treatment
    Milestone payment from Sanofi to Schrödinger for providing molecular simulation, computational design expertiseMilestone payment from Sanofi to Schrödinger for providing molecular simulation, computational...
    USFDA clears Centerline flagship product Intra-Operative Positioning SystemUSFDA clears Centerline flagship product Intra-Operative Positioning System
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X